SRI International was awarded a seven-year, $49m contract from the NIAID (National Institute of Allergy and Infectious Diseases), which is a division of the NIH (National Institutes of Health), for preclinical HIV/AIDS work.
According to the results of a new survey HIV patients are in the
dark about treatment options and the significance of drug
resistance, not only jeopardising their own health but also
potentially exacerbating the problem of limited...